| | BioNTech Provides Strategic Business Update and Outlines 2026 (biontech.de) |
| 2 points by doener 2 days ago | past | discuss |
|
| | Clinically Meaningful Survival Benefit for Patients with Cell Lung Cancer (biontech.de) |
| 1 point by doener 38 days ago | past | 1 comment |
|
| | BioNTech to Host Innovation Series R&D Day on November 11, 2025 (biontech.de) |
| 1 point by doener 77 days ago | past |
|
| | BioNTech to Host Second AI Day (biontech.de) |
| 3 points by doener 3 months ago | past |
|
| | BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership (biontech.de) |
| 2 points by doener 7 months ago | past |
|
| | Building a global immunotherapy powerhouse translating science into survival (biontech.de) |
| 4 points by lawrenceyan 9 months ago | past |
|
| | BioNTech to Host AI Day as an Edition of Its Innovation Series (biontech.de) |
| 1 point by doener on Sept 19, 2024 | past |
|
| | BionTech: Lift of Partial Clinical Hold for BNT326/YL202 (biontech.de) |
| 2 points by doener on Aug 19, 2024 | past |
|
| | Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 (biontech.de) |
| 2 points by doener on July 30, 2024 | past |
|
| | BioNTech Receives FDA Fast Track Designation for Antibody-Drug Conjugate (biontech.de) |
| 2 points by doener on June 26, 2024 | past |
|
| | BioNTech presents positive phase 1/2 data for CAR-T cell therapy candidate (biontech.de) |
| 232 points by doener on Oct 24, 2023 | past | 95 comments |
|
| | BioNTech-InstaDeep Early Warning System to Detect High-Risk SARS-CoV-2 Variants (biontech.de) |
| 149 points by adsodemelk on Jan 11, 2022 | past | 64 comments |
|
| | BioNTech Plans to Address Infectious Diseases on the African Continent (biontech.de) |
| 103 points by mpweiher on Aug 8, 2021 | past | 6 comments |
|
| | BioNTech First Quarter Presentation [pdf] (biontech.de) |
| 3 points by lapalmian on May 10, 2021 | past |
|
| | Statement Regarding Cyber Attack on European Medicines Agency (biontech.de) |
| 3 points by mudil on Dec 9, 2020 | past |
|
| | Pfizer and BioNTech Conclude Phase 3 Study of Covid-19 Vaccine Candidate (biontech.de) |
| 264 points by doener on Nov 18, 2020 | past | 171 comments |
|
| | Pfizer and BioNTech Announce Vaccine Candidate Against Covid-19 Achieved Success (biontech.de) |
| 3 points by doener on Nov 9, 2020 | past |
|
| | BioNTech initiates submission to EMA for SARS-CoV-2 vaccine candidate BNT162b2 (biontech.de) |
| 2 points by lawrenceyan on Oct 8, 2020 | past |
|
| | BioNTech and Pfizer announce first clinical trial of Covid-19 vaccine candidates [pdf] (biontech.de) |
| 1 point by lornemalvo on April 22, 2020 | past |
|
